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Objective: This study tested the implication of pathologic fractures on the prognosis in stage IIb osteosarcoma.
Methods: A single center retrospective evaluation of clinical management and oncologic outcome was conducted
with 15 pathological fracture patients (M:F = 10:5; age: mean 23.2, range 12–42) and 50 non-fracture patients
between April 2002 and December 2010. These stage IIB osteosarcoma patients were matched for age, tumor site
(femur, tibia, and humerus), and osteosarcoma subtype (i.e., control patients with osteosarcoma in the same sites as
the fracture patients). All osteosarcoma patients with pathological fractures underwent brace or cast immobilization,
adjuvant chemotherapy, and limb salvage surgery or amputation. Musculoskeletal Tumor Society (MSTS) functional
scores were assessed. The mean follow-up time was 34.7 months (range, 8–47 months).
Results: Following limb salvage surgery, no statistical differences were observed in major complications
(fracture = 20.0%, control = 12.0%, P = 0.43) or local recurrence complications (fracture = 26.7%, control = 14.0%,
P = 0.25). Overall 3-year survival rates of the fracture and control groups (66.7% and 75.3%, respectively) were not
statistically different (P = 0.5190). Three-year disease-free survival rates of the fracture and control groups were
53.3% and 66.5%, respectively (P = 0.25).
Conclusions: Pathologic fracture was not a prognostic indicator of recurrence or overall survival in localized
osteosarcoma patients. Limb salvage can be achieved by and maintaining adequate surgical margins and applying
adjuvant chemotherapy.
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Pathologic fracture occurs in as many as 5% to 10% of
all osteosarcoma patients, affecting patients both at the
time of diagnosis and during chemotherapy treatment
[1-3]. In the past, pathologic fracture of the extremities
caused by localized osteosarcoma has been considered
an absolute indication for amputation of the affected
limb [1,4]. Recent advances in multi-agent adjuvant
chemotherapy, surgical techniques, and radiographic
imaging have not only dramatically improved overall
prognosis in these patients, but also made limb salvage
surgeries feasible [5]. Contemporary applications of such
conservative treatments, however, have sparked contro-
versy about the actual impact of these techniques on* Correspondence: yingqi.hua@yahoo.com; zhdcai@126.com
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reproduction in any medium, provided the orpatient outcomes, including function independence and
quality of life.
Amputation procedures have been traditionally
recommended for osteosarcoma patients exhibiting
pathological fractures based on the theory that frac-
ture-induced hematomas increase the risk of unex-
pected micro-metastasis [6-8]. This widely published
theory resulted in the observation that pathological
fracture occurrence was directly and significantly
linked with prognosis and, more specifically, with the
higher mortality rates related to metastatic cancer
progression [9]. Several recent studies have, however,
demonstrated that pathological fracture has no prog-
nostic significance in patients with high-grade extrem-
ity osteosarcoma [10,11]. Such fractures are also poor
indictors of local recurrence risk, though an associ-
ation with increased mortality rate has been reported
[12]. Conversely, a multi-center study conducted through. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(MSTS) revealed findings supporting the use of pathologic
fracture as an indicator of local recurrence and mortality
risks in osteosarcoma patients [5]. Thus, a significant
controversy pertaining to the usefulness of pathological
fracture as a prognostic indicator of both mortality and
recurrence has appeared in current scientific literature.
The body of published work examining pathological
fracture in osteosarcoma patients has grown in recent
decades, including numerous single center [10-19] and
multi-center studies [5]. Unfortunately, the relative rarity
of osteosarcoma patients has commonly resulted in in-
adequate matching of experimental and control sub-
jects, with most studies including patients matched for
cancer stage only. Because these study designs conduct
comparisons without considering important parame-
ters, such as patient age, classification, and lesion site,
broad application of these findings is not possible. Fur-
thermore, few of these studies have directly reported
the occurrence of pathological fracture cases with ap-
propriately matched controls. These omissions may be
a primary contributor to the discrepancy between re-
ports of the prognostic value of pathological fracture in
these patients.
While the prognostic value of pathological fractures
remains a subject of intense debate, proper surgical
treatment for these fractures is equally controversial.
Limb salvage, avoiding amputation, has been recently
linked with direct benefits in several psychological fac-
tors and total quality of life. Psychometric parameters
were significantly improved in limb salvage patients
compared to amputees, and limb salvage patients ex-
hibited improved material well being through increased
success in occupational relations, creative-aesthetic
behaviors, and sports activities [20]. In order to avoid
amputation and thus preserve patient quality of life for
osteosarcoma patients, improving conservative limb
salvage strategies is of great clinical importance.
Only in recent decades have contemporary treatments
applying improved surgical technologies achieved signifi-
cant success in salvaging extremities affected by patho-
logical osteosarcoma patients. In fact, modern treatment
centers may offer limb salvage surgeries over amputation
to as many as 80% of osteosarcoma patients [21]. Using
adequate margins of excision, limb-sparing results can
be achieved without undue risk of metastatic events,
though surgeons still face the significant challenge of
controlling the elevated rate of local recurrence in af-
fected extremities [13]. One study even reports that limb
salvage patients still exhibited better survival compared
to amputees even when local recurrence occurred, in
part due to more effective treatments for these localized
occurrences. Additionally, the same study reported that
fewer than 10% of limb salvage patients exhibited cancermetastasis [21]. Despite these positive indicators for the
effectiveness of limb salvage surgery combined with
chemotherapy, many treatment centers may still overuse
amputation treatments in cases where limb salvage is
possible.
The current study was designed to assess the prog-
nostic value of pathologic fracture in localized osteo-
sarcoma patients. Additionally, the efficacy of the two
surgical options still widely employed in clinical prac-
tice, amputation and limb salvage, were explored. The
findings provide clinicians and researchers with a bet-
ter understanding of the benefits and limitations of
these surgical alternatives for both improving patient
functional outcomes and reducing mortality risks.
Methods
Study design and patient selection
A retrospective survey of 15 patients (M:F = 10:5; age:
mean 23.2 years, range 12–42 years) with localized pri-
mary osteosarcoma complicated by pathologic fracture
of the extremities (fracture group) and 50 patients with
osteosarcoma without fractures (non-fracture group)
was conducted at the Changhai Hospital of the Second
Military Medical University (Shanghai) between April
2002 and December 2010 and written informed consent
was obtained from the patient for publication of this
report and any accompanying images. Patients of the
fracture and non-fracture groups were matched for age,
tumor stage, lesion site, and osteosarcoma subtype. The
non-fracture group was used as a control group for
evaluation of pathologic fracture as a prognostic indica-
tor and for evaluation of surgical treatment efficacy be-
tween the two groups. Since the pathological fractures
in osteosarcoma patients were diagnosed in proximal
femur, distal femoral, and proximal humerus, we chose
the control patients with osteosarcoma in these sites to
match the fracture patients (Tables 1 and 2).
Patients were included in the fracture group of the
study based on the following: 1) presentation of isolated
localized osteosarcoma lesion of the femur, humerus, or
tibia; 2) diagnosis as high-grade osteosarcoma of classic
subtype (stage Enneking IIB); and 3) no previous surgical
treatment for pathological fracture. Notably, control pa-
tients were included based on the previous criteria 2 and
3, but not criteria 1. Patients excluded were those that
presented with: 1) previous metastasis activity; 2) lesions
in more than one extremity; 3) abnormal biopsy scar; 4)
other cancer history or treatment; 5) tumor involvement
of the neurovascular bundle; 6) multiple pulmonary me-
tastases; and 7) contraindication of chemotherapy. These
criteria were partly based on the recommendation of a
review by Ruggieri et al. [22] for the surgical treatment
of long bone pathological fractures. We also excluded
those patients treated at other institutions.
Table 1 Demographic and characteristic data for 15 cases of pathological fracture associated with stage IIB osteosarcoma
No. Gender Age (year) Site Stage P type Surgery Blood loss (mL) Displacement LR Metastasis CPL RC type FP time (months) DF time Tumor N stage Outcome
1 Male 12 P tibia II B classic LBS 800 no LR + pros 8 7 good dead
2 Female 15 P femur II B p LBS 850 no pros 45 45 good
3 Female 24 P femur II B classic AMP 615 yes 39 39 poor
4 Male 18 P humerus II B classic LBS 705 yes pros 46 46 good
5 Female 34 D femur II B classic AMP 868 yes 44 44 poor
6 Male 19 D femur II B classic LBS 920 no lr pros 39 39 good
7 Male 20 P femur II B classic LBS 1100 no pros 45 45 good
8 Female 35 P humerus II B classic AMP 780 yes LR + 29 24 poor dead
9 Female 22 D femur II B classic LBS 850 no infct pros 47 47 good
10 Female 19 P humerus II B classic LBS 900 no pros 23 22 poor dead
11 Male 24 D femur II B classic LBS 1000 no LR pros 46 36 good
12 Male 42 P humerus II B classic AMP 880 no 40 38 poor dead
13 Male 22 D femur II B classic LBS 780 no + brk pros 18 16 poor dead
14 Male 18 P humerus II B classic LBS 1000 yes LR pros 39 34 good
15 Female 23 D tibia II B classic AMP 940 yes + 12 11 poor dead
Sum/Mean 23.2 865.9 4 4 3 34.7 32.9 6
P type: Pathologic type; classic: Classic osteosarcoma; p: Periosteal osteosarcoma; P: Proximal; D: Distal; AMP: Amputation; LBS: Limb salvage surgery; FP time: Follow-up time; CPL: Complication; RC type: Reconstruction


























fracture (n = 50)
P value (χ2 test)
Age (mean) 23.2±8.0 21.8±12.2 0.69
Stage IIB IIB
Subtype 0.36
Classic 93.3% (14) 98% (49)
Others 6.7% (1) 2% (1)
Tumor site 0.99
Femur 53.3% (8) 54% (27)
Tibia 13.3% (2) 14% (7)
Humerus 33.3% (5) 32% (16)
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histopathological subtype was conventional osteosar-
coma (14/15, 93%). The most commonly involved sites
were the distal femur (5/15, 33%) and the proximal
humerus (5/15, 33%), followed by the proximal femur
(3/15, 20%). Tumor stage was determined as stage IIB
in all patients (15/15, 100%) according to the MSTS
Staging System (Enneking 1986) using local radiog-
raphy, computed tomography (CT) of the chest, and
magnetic resonance imaging (MRI) in the most recent
cases. Of these 15 patients, pathologic fracture was
present in 8 patients (53%) at the time of diagnosis and
occurred in 7 patients (47%) during chemotherapy. De-
mographic and clinical data of the fracture group is
detailed listed in Table 1.
Clinical management and assessment
Each of the 15 patients of the fracture group was
immobilized by standard brace or plaster cast, according
to the method of Scully et al. [5,19]. Patients were then
followed for a minimum of 4 preoperative adjuvant
chemotherapy cycles, according to the National Com-
prehensive Cancer Network (NCCN). In consideration
of the patients’ clinical manifestation, tolerance situation,
and the NCCN protocols, some first-line chemothera-
peutic drugs were administrated preoperatively for 4–6
cycles in our hospital: methotrexate 60 g/m2, adriamycin
420 mg/m2, cisplatin 600 mg/m2, and standard-dose
ifosfamide 30 g/m2.
Chemotherapy-related tumor necrosis rates were
assessed by a senior pathologist, according to the
method of Bacci et al. [23]: good response = tumor ne-
crosis >90%, and poor response = tumor necrosis < 90%.
The patients were assessed by imaging RECIST evalu-
ation criteria, and tumors exhibiting partial response
and above were considered as indication of limb salvage.Postoperative chemotherapy was determined by neo-
adjuvant chemotherapy assessment, tumor necrosis rate,
and pathologic type. Furthermore, combined methotrex-
ate and adriamycin in chemotherapeutic regimens was
avoided due to severe hepatotoxicity.Limb salvage and amputation surgeries
Patients who responded well to chemotherapy treatment
(10/15, 66%) with good symptom relief, fracture healing,
tumor ossification, and increased bone formation upon
radiographic examination were determined to be eligible
for limb salvage surgery. Signs for limb salvage included:
1) large functional muscles since the resection of such
muscles would make reconstruction difficult and func-
tional loss; 2) good chemotherapeutic response because
if chemotherapy could effectively eradicate the tumors,
limb salvage would be of more significance; 3) no distant
signs of metastasis since these would have made the
reconstruction surgery meaningless. Reconstruction type
was based on patients’ willingness, lesion location and
surgical considerations (i.e., margins). The reconstruc-
tion types included: semi-shoulder prostheses (3/15,
20%), rotational hinged knee prosthesis systems (5/15,
33%), and proximal femur defect prostheses (2/15, 13%).
Notably, personal preference of the patient was also con-
sidered when determining eligibility for limb salvage
treatment.
Prosthesis reconstruction was applied in all cases of
limb salvage surgery in the present study in order to re-
duce complication risks. Potential severe complications
of limb salvage surgery included non-union at the graft-
host junction, fatigue fracture, articular collapse, disloca-
tion, degenerative joint disease, and failure of ligament
attachments caused by allograft and allograft-prosthesis
composite reconstruction techniques. Reconstruction of
the distal femur was achieved using minimally invasive
single medial incisions. We approached the incision of
anterior-medialis of the quadriceps femoris (instead of
bisecting it), to prevent the dysfunction of the extensor
mechanism postsurgery.
The popliteal tendon and medial gastrocnemius were
then transferred to cover the prosthesis and partially
reconstruct the quadriceps region. Lesions of the distal
humerus were reconstructed using modified Tikhoff-
Linberg procedures [24]. Brachioradialis, pronator, and
flexor carpi radialis muscles were sutured to the re-
maining biceps and triceps muscles to secure the soft
tissues around the flared distal portion of the humeral
prosthesis following prosthesis construction. Recon-
struction of proximal femur fractures was achieved
with proximal femur defect prosthesis combined with
bone cement after resection of proximal femur. The
remaining abductor was lowered to the proximal aspect
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Dacron tape.
Surgical amputations of the affected extremity were
conducted in five patients (33%) due to poor response
to preoperative chemotherapy or insufficient surgical
margins for limb salvage surgery. Above-knee amputa-
tions were performed in two patients (13%), forequarter
amputation was performed in one patient (7%), and one
patient (7%) underwent below-knee amputation.
Intraoperative tumor biopsies were taken from each
patient from further laboratory analysis. All patients
were subsequently transferred to the intensive care unit
and closely observed for 24 hours following either am-
putation or limb salvage procedures. All patients under-
went chemotherapy 3 weeks after surgery. Specialized
rehabilitation schedules were proposed to aid in recov-
ery of normal bodily functions. Notably, patients with
fractures of the proximal tibia were immobilized for 3
weeks to ensure the stable connection of the extensor.
Assessment of surgical parameters and postoperative
outcomes
For patients of both the fracture and non-fracture (con-
trol) group, intraoperative blood loss and the surgical
margin parameters (pseudocapsule rupture, and surgical
margins) were recorded and analyzed. Surgical margins
were assessed according to the system of Enneking et al.
[25]. Wide margins of soft tissues were defined as tumor
invaded mesooecium, which were determined by MRI.
Osseous tissues were resected 3–4 cm away from the
abnormal MRI signal area. Wide margin determination
helped the resection. The borderline of the soft tumor
tissues was obscure, and thus the suspicious tissues were
resected along with the normal tissues. Additionally,
biopsied tumor specimens were collected and assessed
by senior pathologists in the current facility. The time
taken for each patient to begin weight-bearing activities
and walking were recorded.
All patients of both the fracture and non-fracture
groups were observed in the outpatient clinic on an
ongoing basis following discharge until either relapse or
death was reported. General follow-up assessments
included a physical examination, plain radiograph, CT
scan, and bone scan (ECT). Bone scanning was per-
formed to observe the existence of concentration phe-
nomena in the bone area, which was used to position
and observe the osteosarcoma recurrence after surgery.
Usually, bone scanning was performed every 6 months
during the 3 years post-surgery.
Additionally, the functionality of the affected limb was
assessed every 2 months in the first 2 years following
surgery, every 3 months in the third year, and every 6
months thereafter. Functional evaluation was conducted
using MSTS scores, including six categorical scores forpain, function, emotional acceptance, use of supports,
walking ability, and gait. These items were assessed with
a 5-point scoring method with a maximum possible
score of 30, according to the method provided by
Enneking et al. [26]. Outcomes including immediate
local complications (i.e., swelling and pain), recurrence
(assessed by X-ray), and metastasis (determined by chest
CT scanning) were reported along with the 3-year over-
all survival (OS) and disease-free (DFS) survival rates.
Statistical analysis
All data were statistically analyzed using SPSS v.13.0
(SPSS, Inc., Chicago, IL, USA) and expressed as mean
values ± standard deviation (SD), and categorical data
were described as absolute frequencies. The 3-year OS
rate, 3-year DFS rate, and local recurrence between
patients with and without pathologic fracture were eval-
uated using χ2 tests or fisher’s exact tests. MSTS score
comparison was completed using Student’s t-tests. All
survival data, including both OS and DFS, were analyzed
using the Kaplan-Meier method and a log-rank test.
Statistical significance was defined as P values less than
or equal to 0.05 (P ≤ 0.05).
Results
Demographic and clinical findings in patients with and
without pathological fractures
Patients with pathologic fractures (n = 15) had a mean age
of 23.2±8.0. Compared with the mean age of 21.8±12.2 in
patients without pathologic fracture (n = 50), no signifi-
cant difference was observed (P = 0.69). Patients with and
without pathologic fractures exhibited stage IIB tumors
with classic subtypes (14 vs. 49 patients, respectively) or
other subtypes (1 vs. 1 patient, respectively), indicating no
significant difference between these patient groups (P =
0.36). No significant differences were observed in tumor
sites in patients with and without pathologic fractures,
presenting in the femur (8 vs. 27 patients, respectively),
tibia (2 vs. 7 patients, respectively), and humerus (5 vs. 16
patients, respectively) (P = 0.99) (Table 2).
Oncologic outcomes in patients with pathological
fractures
Wide margin resections (as defined in Patients and
methods [10,25]) were successfully achieved in 13 of 15
patients (86.7%) in the fracture group (5 amputation
patients, 8 limb salvage surgery patients). The mean
duration of surgery was 2.5 h (range, 1.5-3.5 h) and the
mean intraoperative blood loss was 866 mL. Of these
patients, local recurrence was observed in 3 of 10 limb
salvage surgery patients and 1 of 5 amputation patients.
Photographic and radiographic images of localized os-
teosarcoma complicated by pathologic fracture of the
humerus in an 18-year old patient are shown in Figure 1.
Figure 1 Localized osteosarcoma complicated by pathologic fracture of the humerus in an 18-year old patient. (a) X-ray of A-P position
for patient at presentation; (b) Preoperative MRI indicating extraosseous lesion and undisplaced fracture of the humerus; (c) The resected
specimen including the proximal humerus and biceps at the osteotomy level; (d) Reconstruction with semi-shoulder prosthesis; (e) Postoperative
X-ray of affected arm.
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Complications occurred in three limb salvage surgery
patients. A 19-year-old boy presented with a loosened
prosthesis 2 years after rotational hinged knee prosthesis
reconstruction surgery, requiring revision surgery. A 22-
year-old female suffered deep wound infection, requiring
positive dressing and antibiotic administration for 3
months. In this case, poor wound healing resulted in
secondary treatment by amputation. Femoral prosthesis
breakage was observed in a 27-year old male 5 months
after limb salvage and reconstruction surgery, requiring
secondary prosthesis reconstruction surgery. This case
resulted in death due to pulmonary metastasis 13
months after the second surgery. Additionally, four
patients developed pulmonary metastasis leading to
death (Table 3).
MSTS scores and functional outcomes
In the fracture group, the mean MSTS scores of limb sal-
vage surgery patients were significantly higher comparedto those of patients that underwent amputation (23.5 vs.
18.8, respectively) (P = 0.0002). Functional preservation
was significantly better in limb salvage patients than pa-
tients that underwent amputation in both groups, with all
surviving patients able to lead independent lives. Notably,
five patients in the fracture group were able to partake in
simple physical activities, such as jogging.
Comparison of patients with and without pathologic
fracture
The 3-year OS rate for fractured patients was 66.7% vs.
75.3% in patients without pathological fracture. OS and
DFS percentage by month are shown in Figure 2a and b.
Patients without pathologic fracture showed relatively
higher survival rates, but no significant difference were
observed between patients with and without pathological
fractures (P = 0.5190). The 3-year DFS rate for fracture
group was 53.3% vs. 66.5% in the control group (P =
0.2466), and the local recurrence rate of the fracture
group was 26.7% vs. 14% in the control group (Table 3,
Table 3 Surgical data, MTST scores, and clinical outcomes of patients with or without pathologic fracture
Pathologic fracture patients (n = 15) Non-fracture patients (n = 50) P value (χ2 test, Student's t-test)
Surgical technique
Amputation 5 4
(Mean MTST score) 18.8±3.5 21.2±4.6 0.040
Limb salvage 10 46
(Mean MTST score) 23.5±3.9 25.3±4.2 0.219
Surgical margin
Pseudocapsule rupture 14 (93.3%) 5 (10.0%) <0.001
Wide margin 13 (86.7%) 44 (88.0%) 0.890
Other margins 2 (13.3%) 6 (12.0%)
Outcomes
Recurrence 4 (26.7%) 7 (14.0%) 0.25
Complications 3 (20%) 6 (12.0%) 0.43
Metastasis 4 (26.7%) 16 (32.0%) 0.69
3-year DFS 53.3% 66.5% 0.25
3-year OS 66.7% 75.3% 0.52
MSTS: Musculoskeletal Tumor Society; DFS: Disease-free survival; OS: Overall survival.
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served in the gender and age distribution in the fracture
group.
In the fracture group, 14 of 15 patients (93%) avoided
rupture of the tumor pseudocapsule, whereas only six
cases (12%) were observed in the 50 patients of the con-
trol group (P = 0.000001). Wide surgical margins were
achieved in 13 of 15 patients (86.7%) in the fracture
group, vs. 44 of 50 patients (88%) in the control group
(P = 0.890), with no statistical difference observed
between groups. A total of 10 patients in the fractureFigure 2 Overall and disease-free survival percentage by month. (a) K
overall survival rate between patients in the study and control groups; (b)
disease-free survival rate between patients in the study and control groupsgroup underwent limb salvage surgery, while only four
patients failed of the control group were ineligible for
limb salvage surgery (P = 0.039).
Discussion
The current study details the experiences of a single hos-
pital in management of patients with localized osteosar-
coma complicated by pathologic fracture. We attempted
to ascertain whether pathological fracture had prognostic
significance or affected the efficacy of surgical limb sal-
vage. Our study did not show significant differencesaplan-Meier survival curve indicates no statistical difference in the
Kaplan-Meier survival curve indicates no statistical difference in
.
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come measures that were evaluated, namely recurrence,
complications, metastasis, 3-year DFS, or 3-year OS.
Therefore, we concluded, in our hospital setting, the
presence of a pathologic fracture was not a prognostic
indicator of recurrence or overall survival in localized
osteosarcoma patients.
This study shows that a cooperative multidisciplinary
approach involving orthopedic oncologists, medical on-
cologists, radiologists, pathologist, radiologists special-
izing in bone and soft tissue tumors, reconstructive
surgeons, and physiotherapists, is required to effectively
treat individual patients. Unfortunately, many medical
facilities do not have access to this diverse set of clini-
cians, potentially limiting patient outcomes. Although
several different postoperative complications were ob-
served, all surviving patients exhibited good functional-
ity at the final follow-up. When possible, limb salvage
should be considered for these patients, as success rates
of limb-preserving surgeries are dramatically higher that
those observed only a few decades ago.
Successful limb salvage treatment should be consid-
ered in fractured patients with localized limb osteosar-
coma that does not invade major neurovascular bundles
or major regional muscles. In addition, the current study
demonstrated that patients who respond well to pre-
operative chemotherapy without evidence of tumor skip
or transfer may undergo limb-sparing treatment with
minimal risk of metastasis. In order to further prevent
such metastatic occurrences and prevent recurrence,
wide surgical margins for complete resection of tumor
are critical factors that affect the rate of local
recurrence.
In the current study, certain limb salvage surgery cases
presented unusual complications, such as femoral fatigue
fracture and prosthetic loosening following reconstruc-
tion. It is well known that oncologic reconstruction in-
volves higher complication rates than standard total
joint arthroplasty [27]. This observation is primarily due
to the extensive nature of the operation, involving sig-
nificant tissue loss, and the compromising effect of as-
sociated chemotherapy. To mediate this relatively high
rate of complications, risks and types of complications
should be carefully assessed, particularly in physically
active adolescent and young adult patients. Additionally,
prosthesis construction should be carefully considered,
as the present study showed that soft tissue transfer
played an important role in both functional restoration
and wound healing.
The prognostic importance of pathologic fractures in
localized limb osteosarcoma and local disease control
has been varied in the published literature. Ferguson
et al. [12] compared oncological and functional out-
comes of 201 patients with high-grade osteosarcomawithout pathologic fracture to 31 patients with patho-
logic fractures, concluding that pathologic fracture was
associated with decreased overall survival but not associ-
ated with local recurrence. These results were confirmed
by subsequent studies [5,15]. In order to assess the value
of pathological fracture as a prognostic indicator, the
current study showed that clinical outcomes of limb sal-
vage surgery and amputation resulted in different OS
rates, DFS rates, and local recurrence. Consistent with
the current study, numerous previous studies [4, 10, 14,
18, 23] have demonstrated that pathologic fractures, when
treated with sufficient preoperative and postoperative
chemotherapy and resected with adequate surgical mar-
gins, have no significant association with survival rate.
The current findings suggest that limb-sparing treat-
ments can be successfully applied in many cases of local-
ized limb osteosarcoma. In fact, limb salvage surgery
produced significantly superior results in patients with
and without pathological fractures, resulting in better
functional outcomes. While limited in previous decades
by the lack of sophisticate radiographic techniques and
precision surgical tools, limb salvage surgery in contem-
porary clinical settings, coupled with modern chemo-
therapy, may be more effective than previously reported.
Tumor size has been shown to be an important risk
factor for osteosarcoma patients [12]. However, tumor size
measurements, conducted by MRI, may be inaccurate due
to collapse or displacement that occurs secondary to frac-
ture. Similar inaccuracies in tumor measurements may
also occur in the presence of significant hematoma in the
adjacent tissues [10,17]. To overcome this potential source
of error, proximal location is sometimes more carefully
considered than tumor size [15]. Bacci et al. [14] reported
that humeral or diaphyseal location was an important
risk factor in cases of pathologic fracture. Because
radiographic imaging volumes were applied in the
present study, tumor volumes may be somewhat in-
accurate; however, this error was likely minimized in
the absence of hematoma and tumor invasion.
Conclusions
The current study examined patients receiving both limb
salvage and amputation surgery. As suggested by Scully
et al. [5], it reduces bias due to stratification by treat-
ment strategy by reporting on both prognostic indicators
and treatment strategies. The findings of the current
study may, however, be limited by the assessment of
tumor margin and pseudocapsule by the expert opinion
of only a single surgeon and the relatively small number
of included patients. This relatively small cohort pre-
cludes certain statistical analyses that would be interest-
ing if demonstrated on a larger scale. Due to the rarity
of the condition in the general population, obtaining a
large cohort at a single center would be challenging, and
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analysis of these patients. A benefit of this study, however,
is that the small patient number ensured that all included
patients underwent follow-up until death or recurrence,
with no exceptions. Further, unlike many retrospective
studies, the experimental and control groups are matched
for age, tumor stage, tumor site, and subtype, lending fur-
ther credibility to the current findings.
Pathologic fracture was not shown to be a prognostic
indicator for OS or DFS in localized primary osteosar-
coma patients. Modern technology and imaging allows
improved results in limb salvage surgery, producing
satisfactory oncologic outcomes when adequate surgical
margins are applied and combined with regular adjuvant
chemotherapy. Unlike amputation surgery, limb-sparing
treatments allow greater functional restoration and gen-
erally produce more positive overall patient outcomes.
However, due to the risk of severe postoperative compli-
cations, patients and clinicians should carefully consider
the risks associated with both amputation and limb
salvage surgeries. While future study will be required
before broad clinical recommendations can be made for
treatment selection, the current study provides an im-
portant resource for future, evidence-based clinical
studies.
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